Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group (Q34057488)

30 July 2017

Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group (English)

1 reference

30 July 2017

1 reference

Dewys WD

1

1 reference

30 July 2017

Begg C

2

1 reference

30 July 2017

Lavin PT

3

1 reference

30 July 2017

Band PR

4

1 reference

30 July 2017

Bennett JM

5

1 reference

30 July 2017

Bertino JR

6

1 reference

30 July 2017

Cohen MH

7

1 reference

30 July 2017

Douglass HO Jr

8

1 reference

30 July 2017

Engstrom PF

9

1 reference

30 July 2017

Ezdinli EZ

10

1 reference

30 July 2017

Horton J

11

1 reference

30 July 2017

Johnson GJ

12

1 reference

30 July 2017

Moertel CG

13

1 reference

30 July 2017

Oken MM

14

1 reference

30 July 2017

Perlia C

15

1 reference

30 July 2017

Rosenbaum C

16

1 reference

30 July 2017

Silverstein MN

17

1 reference

30 July 2017

Skeel RT

18

1 reference

30 July 2017

Sponzo RW

19

1 reference

30 July 2017

Tormey DC

20

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 October 1980

1 reference

American Journal of Medicine

30 July 2017

1 reference

30 July 2017

69

1 reference

30 July 2017

491-497

1 reference

30 July 2017

4

1 reference

Results of a E.O.R.T.C. randomized trial of cyclophosphamide and radiotherapy in inoperable lung cancer: Prognostic factors and treatment results

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2805%2980001-3

7 January 2021

Survival with inoperable lung cancer: an integration of prognostic variables based on simple clinical criteria.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2805%2980001-3

7 January 2021

Cyclophosphamide, cytosine arabinoside and methotrexate versus cytosine arabinoside and thioguanine for acute non-lymphocytic leukemia in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2805%2980001-3

7 January 2021

Chemotherapy of disseminated breast cancer:Current status and prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2805%2980001-3

7 January 2021

Chemotherapy of advanced measurable colon and rectal carcinoma with oral 5-fluorouracil, alone or in combination with cyclophosphamide or 6-thioguanine, with intravenous 5-fluorouracil or beta-2'-deoxythioguanosine or with oral 3(4-methyl-cyclohexyl

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2805%2980001-3

7 January 2021

Eastern cooperative oncology group experience with the rappaport classification of non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2805%2980001-3

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2805%2980001-3

7 January 2021

Anorexia as a general effect of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2805%2980001-3

7 January 2021

Skeletal muscle metabolism in patients with malignant tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2805%2980001-3

7 January 2021

Metabolic observations during the forced feeding of patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2805%2980001-3

7 January 2021

Abnormalities of taste sensation in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2805%2980001-3

7 January 2021

DENSITOMETRIC ANALYSIS OF BODY COMPOSITION: REVISION OF SOME QUANTITATIVE ASSUMPTIONS

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2805%2980001-3

7 January 2021

10.1016/S0149-2918(05)80001-3

Identifiers

DOI

1 reference

30 July 2017

1 reference